ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Nuo Therapeutics Inc (QB)

Nuo Therapeutics Inc (QB) (AURX)

0,9608
0,00
(0,00%)
Geschlossen 11 Juli 10:00PM

Nuo Therapeutics Inc (QB) (AURX) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-30Mr. David E. JordenCEO, CFO, Secretary & Executive Director-160,89k1,61kDerivative Exercise and Sale1,00 - 1,012,06M-
2026-06-30Mr. David E. JordenCEO, CFO, Secretary & Executive Director1,61k1,61kDerivative Exercise and Retained Stock1,002,06M0,08%
2026-06-30Mr. Scott M. PittmanIndependent Director-39,60k396,04Derivative Exercise and Sale1,00 - 1,015,40M-
2026-06-30Mr. Scott M. PittmanIndependent Director396,00396,00Derivative Exercise and Retained Stock1,005,40M0,01%
2026-06-30Mr. C. Eric WinzerIndependent Director-39,60k396,04Derivative Exercise and Sale1,00 - 1,01173,05k-
2026-06-30Mr. C. Eric WinzerIndependent Director396,00396,00Derivative Exercise and Retained Stock1,00173,05k0,23%
2026-01-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director99,62k39,85kDerivative Exercise and Retained Stock0,402,05M5,12%
2026-01-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director-25,38k39,85kDerivative Exercise and Sale0,40 - 1,972,05M-
2025-12-17Mr. C. Eric WinzerIndependent Director55,00k22,00kDerivative Exercise and Retained Stock0,40172,65k46,75%
2025-12-17Mr. C. Eric WinzerIndependent Director-13,75k22,00kDerivative Exercise and Sale0,40 - 2,00172,65k-
2025-12-09Prof. Paul David MintzIndependent Director40,91k16,36kDerivative Exercise and Retained Stock0,40108,29k60,71%
2025-12-09Prof. Paul David MintzIndependent Director-9,09k16,36kDerivative Exercise and Sale0,40 - 2,20108,29k-
2025-11-28Mr. David E. JordenCEO, CFO, Secretary & Executive Director-200,00k300,00kVerkauf1,501,95M-9,32%
2025-08-01Mr. C. Eric WinzerIndependent Director92,65k37,06kDerivative Exercise and Retained Stock0,40117,65k370,62%
2025-08-01Mr. C. Eric WinzerIndependent Director-27,66k37,06kDerivative Exercise and Sale0,40 - 1,74117,65k-
2025-08-01Prof. Paul David MintzIndependent Director67,39k26,95kDerivative Exercise and Retained Stock0,4067,39k-
2025-08-01Prof. Paul David MintzIndependent Director-20,12k26,95kDerivative Exercise and Sale0,40 - 1,7467,39k-
2025-08-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director171,40k68,56kDerivative Exercise and Retained Stock0,402,15M8,68%
2025-08-01Mr. David E. JordenCEO, CFO, Secretary & Executive Director-21,31k28,56kDerivative Exercise and Sale0,40 - 1,742,15M-
2025-07-31Dr. Peter Anton ClausenCOO & Chief Scientific Officer183,85k73,54kDerivative Exercise and Retained Stock0,40773,53k31,18%
2025-07-30Mr. Charles Edmund SheedyInsider133,33k200,00kKauf1,5011,57M1,17%